Taken together, we presented evidence that cyperenoic acid from C. crassifolius interferes with RANKL/RANK signaling at least at the non-canonical NF-kB pathway and the osteoclast differentiation process and might be a potential lead compound for osteoporosis therapeutic and prevention in senile osteoporosis. The gene discussed is NFKB1; the disease is osteoporosis.